Corporate Update: Airwa and Peer Activity
Airwa (YYAI) concluded a trading day on Wednesday, 21 October 2026, with a modest 1.34 % increase, closing at USD 0.71 per share. The ticker’s current supply stands at 4.6 million shares, translating into a market capitalization of USD 3.1 million. During the preceding 24 hours, roughly USD 90.9 k of Airwa shares changed hands, a figure that represents a small fraction of the daily trading volume for the broader market.
Historical Performance and Technical Indicators
- Year‑to‑date trend: Airwa has declined by 7.83 % since the close of the prior month, underscoring a relatively weak performance over the past 30 days.
- Moving average: The 200‑day simple moving average sits at USD 404.76, well above the current trading level, indicating a significant short‑term support gap.
- 52‑week range: The highest price recorded in the past year was USD 4,880 (23 October 2025), while the low of the same period was USD 0.64 (20 October 2026). Airwa’s present price lies near the lower bound of this range, suggesting limited upside potential in the absence of fundamental catalysts.
Peer Activity in the Last 24 Hours
| Symbol | % Change | Current Price (USD) | Market Cap (USD) |
|---|---|---|---|
| FLYE | –3.18 % | 2.06 | 3.6 m |
| DRMA | +1.16 % | 0.82 | 3.5 m |
| XPON | +3.99 % | 4.00 | 3.6 m |
| BGLC | –1.87 % | 1.20 | 3.6 m |
| CTNT | –5.20 % | 2.50 | 3.7 m |
Fly‑e (FLYE)
Fly‑e’s share price fell 3.18 % to USD 2.06, with a market cap of USD 3.6 million. The company announced a special meeting of shareholders scheduled for 13 November 2026, aimed at approving a capital‑raising package comprising common stock, warrants, and convertible notes. The outcome will determine whether the firm can comply with Nasdaq listing rules and secure the necessary capital for expansion. Shareholders have been advised to review the proxy statement and to submit their votes via multiple channels.
Dermata Therapeutics (DRMA)
Dermata’s shares advanced 1.16 % to USD 0.82, maintaining a market cap of USD 3.5 million. The company has filed a disclosure confirming that it meets regulatory prerequisites to proceed with a public offering. The filing, lodged with the SEC, includes standard corporate information and indicates readiness to advance the planned transaction.
Expion Energy (XPON)
XPON’s price rose 3.99 % to USD 4.00, with a market cap of USD 3.6 million. No additional corporate actions were reported during the 24‑hour window.
Bionexus Gene Lab (BGLC)
BGLC’s shares slid 1.87 % to USD 1.20, sustaining a market cap of USD 3.6 million. No new developments were disclosed in the period under review.
Cheetah Net Supply Chain Service (CTNT)
CTNT’s shares declined 5.20 % to USD 2.50, with a market cap of USD 3.7 million. The company has filed a definitive consent solicitation, proposing a comprehensive board replacement through Takeover Time 2026 LLC. The plan targets a new five‑member board and addresses concerns over recent equity issuances, reverse stock splits, internal controls, and financial reporting. The solicitation’s success would enable the company to re‑structure its governance framework and potentially restore investor confidence.
About Airwa
Airwa, a subsidiary of Connexa Sports Technologies Inc., operates in the connected sports sector. Its product suite spans wearable devices, interactive play platforms, and subscription‑as‑a‑service models designed to transform how sports are experienced, consumed, and monetized. The company is Nasdaq‑listed and maintains an online presence at www.connexasports.com .